nodes	percent_of_prediction	percent_of_DWPC	metapath
Zileuton—CYP3A4—Fingolimod—multiple sclerosis	0.0946	0.223	CbGbCtD
Zileuton—CYP3A4—Methylprednisolone—multiple sclerosis	0.061	0.144	CbGbCtD
Zileuton—CYP3A4—Triamcinolone—multiple sclerosis	0.0462	0.109	CbGbCtD
Zileuton—CYP3A4—Mitoxantrone—multiple sclerosis	0.0445	0.105	CbGbCtD
Zileuton—CYP2C9—Dexamethasone—multiple sclerosis	0.0397	0.0934	CbGbCtD
Zileuton—CYP3A4—Betamethasone—multiple sclerosis	0.0397	0.0933	CbGbCtD
Zileuton—CYP3A4—Prednisolone—multiple sclerosis	0.0391	0.0921	CbGbCtD
Zileuton—CYP3A4—Prednisone—multiple sclerosis	0.037	0.087	CbGbCtD
Zileuton—Traumatic liver injury—Fingolimod—multiple sclerosis	0.0263	0.0797	CcSEcCtD
Zileuton—Chronic liver disease—Methotrexate—multiple sclerosis	0.0253	0.0765	CcSEcCtD
Zileuton—CYP3A4—Dexamethasone—multiple sclerosis	0.0231	0.0543	CbGbCtD
Zileuton—Liver injury—Fingolimod—multiple sclerosis	0.0117	0.0353	CcSEcCtD
Zileuton—White blood cell count decreased—Mitoxantrone—multiple sclerosis	0.00734	0.0222	CcSEcCtD
Zileuton—Hepatotoxicity—Azathioprine—multiple sclerosis	0.00585	0.0177	CcSEcCtD
Zileuton—Liver injury—Azathioprine—multiple sclerosis	0.00537	0.0163	CcSEcCtD
Zileuton—Sinusitis—Fingolimod—multiple sclerosis	0.00515	0.0156	CcSEcCtD
Zileuton—Upper respiratory tract infection—Cladribine—multiple sclerosis	0.00324	0.00981	CcSEcCtD
Zileuton—Conjunctivitis—Cladribine—multiple sclerosis	0.00302	0.00915	CcSEcCtD
Zileuton—Urinary tract infection—Cladribine—multiple sclerosis	0.00302	0.00915	CcSEcCtD
Zileuton—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.00302	0.00914	CcSEcCtD
Zileuton—Liver disorder—Methotrexate—multiple sclerosis	0.00267	0.00808	CcSEcCtD
Zileuton—Pruritus—Fingolimod—multiple sclerosis	0.00248	0.00749	CcSEcCtD
Zileuton—Abdominal pain upper—Mitoxantrone—multiple sclerosis	0.00242	0.00733	CcSEcCtD
Zileuton—Flatulence—Cladribine—multiple sclerosis	0.00239	0.00725	CcSEcCtD
Zileuton—Diarrhoea—Fingolimod—multiple sclerosis	0.00239	0.00724	CcSEcCtD
Zileuton—Hepatotoxicity—Methotrexate—multiple sclerosis	0.00236	0.00713	CcSEcCtD
Zileuton—Dizziness—Fingolimod—multiple sclerosis	0.00231	0.007	CcSEcCtD
Zileuton—Ill-defined disorder—Cladribine—multiple sclerosis	0.00225	0.00682	CcSEcCtD
Zileuton—Headache—Fingolimod—multiple sclerosis	0.00219	0.00663	CcSEcCtD
Zileuton—Malaise—Cladribine—multiple sclerosis	0.00219	0.00663	CcSEcCtD
Zileuton—Upper respiratory tract infection—Mitoxantrone—multiple sclerosis	0.00213	0.00645	CcSEcCtD
Zileuton—Chest pain—Cladribine—multiple sclerosis	0.00207	0.00626	CcSEcCtD
Zileuton—Myalgia—Cladribine—multiple sclerosis	0.00207	0.00626	CcSEcCtD
Zileuton—Arthralgia—Cladribine—multiple sclerosis	0.00207	0.00626	CcSEcCtD
Zileuton—Discomfort—Cladribine—multiple sclerosis	0.00204	0.00619	CcSEcCtD
Zileuton—Hyperbilirubinaemia—Methotrexate—multiple sclerosis	0.002	0.00606	CcSEcCtD
Zileuton—Jaundice—Mitoxantrone—multiple sclerosis	0.00199	0.00603	CcSEcCtD
Zileuton—Conjunctivitis—Mitoxantrone—multiple sclerosis	0.00199	0.00601	CcSEcCtD
Zileuton—Urinary tract infection—Mitoxantrone—multiple sclerosis	0.00199	0.00601	CcSEcCtD
Zileuton—Sinusitis—Mitoxantrone—multiple sclerosis	0.00192	0.0058	CcSEcCtD
Zileuton—Hepatitis—Mitoxantrone—multiple sclerosis	0.00183	0.00555	CcSEcCtD
Zileuton—Ill-defined disorder—Azathioprine—multiple sclerosis	0.00183	0.00555	CcSEcCtD
Zileuton—Vaginal inflammation—Methotrexate—multiple sclerosis	0.00182	0.00551	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.00181	0.00547	CcSEcCtD
Zileuton—Insomnia—Cladribine—multiple sclerosis	0.00179	0.00543	CcSEcCtD
Zileuton—Malaise—Azathioprine—multiple sclerosis	0.00178	0.00539	CcSEcCtD
Zileuton—Somnolence—Cladribine—multiple sclerosis	0.00176	0.00534	CcSEcCtD
Zileuton—Vaginal infection—Methotrexate—multiple sclerosis	0.00172	0.0052	CcSEcCtD
Zileuton—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.00171	0.00518	CcSEcCtD
Zileuton—Constipation—Cladribine—multiple sclerosis	0.0017	0.00513	CcSEcCtD
Zileuton—Pain—Cladribine—multiple sclerosis	0.0017	0.00513	CcSEcCtD
Zileuton—Arthralgia—Azathioprine—multiple sclerosis	0.00168	0.00509	CcSEcCtD
Zileuton—Myalgia—Azathioprine—multiple sclerosis	0.00168	0.00509	CcSEcCtD
Zileuton—Discomfort—Azathioprine—multiple sclerosis	0.00166	0.00503	CcSEcCtD
Zileuton—Feeling abnormal—Cladribine—multiple sclerosis	0.00163	0.00495	CcSEcCtD
Zileuton—Conjunctivitis—Prednisolone—multiple sclerosis	0.00163	0.00493	CcSEcCtD
Zileuton—Upper respiratory tract infection—Triamcinolone—multiple sclerosis	0.00161	0.00486	CcSEcCtD
Zileuton—Urticaria—Cladribine—multiple sclerosis	0.00158	0.00477	CcSEcCtD
Zileuton—Body temperature increased—Cladribine—multiple sclerosis	0.00157	0.00474	CcSEcCtD
Zileuton—Lymphadenopathy—Methotrexate—multiple sclerosis	0.00155	0.00469	CcSEcCtD
Zileuton—Conjunctivitis—Triamcinolone—multiple sclerosis	0.0015	0.00454	CcSEcCtD
Zileuton—Ill-defined disorder—Mitoxantrone—multiple sclerosis	0.00148	0.00449	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.00147	0.00445	CcSEcCtD
Zileuton—Hypersensitivity—Cladribine—multiple sclerosis	0.00146	0.00442	CcSEcCtD
Zileuton—Malaise—Mitoxantrone—multiple sclerosis	0.00144	0.00436	CcSEcCtD
Zileuton—Pruritus—Cladribine—multiple sclerosis	0.0014	0.00425	CcSEcCtD
Zileuton—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.00139	0.00421	CcSEcCtD
Zileuton—Conjunctivitis—Betamethasone—multiple sclerosis	0.00136	0.00412	CcSEcCtD
Zileuton—Conjunctivitis—Dexamethasone—multiple sclerosis	0.00136	0.00412	CcSEcCtD
Zileuton—Arthralgia—Mitoxantrone—multiple sclerosis	0.00136	0.00412	CcSEcCtD
Zileuton—Myalgia—Mitoxantrone—multiple sclerosis	0.00136	0.00412	CcSEcCtD
Zileuton—Chest pain—Mitoxantrone—multiple sclerosis	0.00136	0.00412	CcSEcCtD
Zileuton—Diarrhoea—Cladribine—multiple sclerosis	0.00136	0.00411	CcSEcCtD
Zileuton—Discomfort—Mitoxantrone—multiple sclerosis	0.00134	0.00407	CcSEcCtD
Zileuton—Feeling abnormal—Azathioprine—multiple sclerosis	0.00133	0.00402	CcSEcCtD
Zileuton—Dizziness—Cladribine—multiple sclerosis	0.00131	0.00397	CcSEcCtD
Zileuton—Body temperature increased—Azathioprine—multiple sclerosis	0.00127	0.00386	CcSEcCtD
Zileuton—Vomiting—Cladribine—multiple sclerosis	0.00126	0.00382	CcSEcCtD
Zileuton—Rash—Cladribine—multiple sclerosis	0.00125	0.00378	CcSEcCtD
Zileuton—Dermatitis—Cladribine—multiple sclerosis	0.00125	0.00378	CcSEcCtD
Zileuton—Headache—Cladribine—multiple sclerosis	0.00124	0.00376	CcSEcCtD
Zileuton—Ill-defined disorder—Prednisolone—multiple sclerosis	0.00122	0.00368	CcSEcCtD
Zileuton—Hypersensitivity—Azathioprine—multiple sclerosis	0.00119	0.0036	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.00119	0.00359	CcSEcCtD
Zileuton—Malaise—Prednisolone—multiple sclerosis	0.00118	0.00358	CcSEcCtD
Zileuton—Nausea—Cladribine—multiple sclerosis	0.00118	0.00357	CcSEcCtD
Zileuton—Somnolence—Mitoxantrone—multiple sclerosis	0.00116	0.00351	CcSEcCtD
Zileuton—Dyspepsia—Mitoxantrone—multiple sclerosis	0.00115	0.00347	CcSEcCtD
Zileuton—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.00112	0.00338	CcSEcCtD
Zileuton—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.00112	0.00338	CcSEcCtD
Zileuton—Constipation—Mitoxantrone—multiple sclerosis	0.00111	0.00337	CcSEcCtD
Zileuton—Pain—Mitoxantrone—multiple sclerosis	0.00111	0.00337	CcSEcCtD
Zileuton—Diarrhoea—Azathioprine—multiple sclerosis	0.0011	0.00334	CcSEcCtD
Zileuton—Discomfort—Prednisolone—multiple sclerosis	0.0011	0.00334	CcSEcCtD
Zileuton—Malaise—Triamcinolone—multiple sclerosis	0.00109	0.00329	CcSEcCtD
Zileuton—Malaise—Methylprednisolone—multiple sclerosis	0.00108	0.00328	CcSEcCtD
Zileuton—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00107	0.00325	CcSEcCtD
Zileuton—Dizziness—Azathioprine—multiple sclerosis	0.00107	0.00323	CcSEcCtD
Zileuton—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.00106	0.00321	CcSEcCtD
Zileuton—Urticaria—Mitoxantrone—multiple sclerosis	0.00104	0.00313	CcSEcCtD
Zileuton—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00103	0.00312	CcSEcCtD
Zileuton—Myalgia—Triamcinolone—multiple sclerosis	0.00103	0.0031	CcSEcCtD
Zileuton—Vomiting—Azathioprine—multiple sclerosis	0.00103	0.0031	CcSEcCtD
Zileuton—Arthralgia—Methylprednisolone—multiple sclerosis	0.00102	0.0031	CcSEcCtD
Zileuton—Myalgia—Methylprednisolone—multiple sclerosis	0.00102	0.0031	CcSEcCtD
Zileuton—Rash—Azathioprine—multiple sclerosis	0.00102	0.00308	CcSEcCtD
Zileuton—Dermatitis—Azathioprine—multiple sclerosis	0.00102	0.00307	CcSEcCtD
Zileuton—Ill-defined disorder—Betamethasone—multiple sclerosis	0.00101	0.00307	CcSEcCtD
Zileuton—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.00101	0.00307	CcSEcCtD
Zileuton—Discomfort—Triamcinolone—multiple sclerosis	0.00101	0.00307	CcSEcCtD
Zileuton—Discomfort—Methylprednisolone—multiple sclerosis	0.00101	0.00306	CcSEcCtD
Zileuton—Headache—Azathioprine—multiple sclerosis	0.00101	0.00306	CcSEcCtD
Zileuton—Conjunctivitis—Methotrexate—multiple sclerosis	0.00099	0.003	CcSEcCtD
Zileuton—Malaise—Dexamethasone—multiple sclerosis	0.000986	0.00298	CcSEcCtD
Zileuton—Malaise—Betamethasone—multiple sclerosis	0.000986	0.00298	CcSEcCtD
Zileuton—LTB4R—GPCR downstream signaling—RGS1—multiple sclerosis	0.000983	0.00402	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—MMP9—multiple sclerosis	0.000982	0.00401	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—CCR2—multiple sclerosis	0.000972	0.00397	CbGpPWpGaD
Zileuton—Insomnia—Prednisolone—multiple sclerosis	0.000967	0.00293	CcSEcCtD
Zileuton—ALOX5—Selenium Micronutrient Network—CCL2—multiple sclerosis	0.000965	0.00395	CbGpPWpGaD
Zileuton—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00096	0.00291	CcSEcCtD
Zileuton—LTB4R—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.00096	0.00392	CbGpPWpGaD
Zileuton—Nausea—Azathioprine—multiple sclerosis	0.000958	0.0029	CcSEcCtD
Zileuton—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000941	0.00385	CbGpPWpGaD
Zileuton—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000941	0.00385	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—GPR65—multiple sclerosis	0.000932	0.00381	CbGpPWpGaD
Zileuton—Myalgia—Betamethasone—multiple sclerosis	0.000931	0.00282	CcSEcCtD
Zileuton—Myalgia—Dexamethasone—multiple sclerosis	0.000931	0.00282	CcSEcCtD
Zileuton—Discomfort—Betamethasone—multiple sclerosis	0.00092	0.00278	CcSEcCtD
Zileuton—Discomfort—Dexamethasone—multiple sclerosis	0.00092	0.00278	CcSEcCtD
Zileuton—Pain—Prednisolone—multiple sclerosis	0.000914	0.00277	CcSEcCtD
Zileuton—Hepatitis—Methotrexate—multiple sclerosis	0.000914	0.00277	CcSEcCtD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000913	0.00373	CbGpPWpGaD
Zileuton—ALOX5—Selenium Micronutrient Network—ALB—multiple sclerosis	0.0009	0.00368	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—CNR1—multiple sclerosis	0.000897	0.00367	CbGpPWpGaD
Zileuton—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000896	0.00271	CcSEcCtD
Zileuton—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000896	0.00366	CbGpPWpGaD
Zileuton—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000896	0.00366	CbGpPWpGaD
Zileuton—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000894	0.00271	CcSEcCtD
Zileuton—LTB4R—Signaling by GPCR—RGS1—multiple sclerosis	0.000893	0.00365	CbGpPWpGaD
Zileuton—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000892	0.0027	CcSEcCtD
Zileuton—Insomnia—Triamcinolone—multiple sclerosis	0.000889	0.00269	CcSEcCtD
Zileuton—Insomnia—Methylprednisolone—multiple sclerosis	0.000887	0.00269	CcSEcCtD
Zileuton—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000884	0.00361	CbGpPWpGaD
Zileuton—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000884	0.00361	CbGpPWpGaD
Zileuton—Ill-defined disorder—Prednisone—multiple sclerosis	0.000883	0.00267	CcSEcCtD
Zileuton—Feeling abnormal—Prednisolone—multiple sclerosis	0.000881	0.00267	CcSEcCtD
Zileuton—Dyspepsia—Triamcinolone—multiple sclerosis	0.000866	0.00262	CcSEcCtD
Zileuton—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000864	0.00261	CcSEcCtD
Zileuton—Malaise—Prednisone—multiple sclerosis	0.000859	0.0026	CcSEcCtD
Zileuton—LTB4R—GPCR downstream signaling—CCR1—multiple sclerosis	0.000852	0.00348	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000852	0.00348	CbGpPWpGaD
Zileuton—Urticaria—Prednisolone—multiple sclerosis	0.00085	0.00257	CcSEcCtD
Zileuton—LTB4R—Signaling by GPCR—GPR65—multiple sclerosis	0.000846	0.00346	CbGpPWpGaD
Zileuton—Pain—Triamcinolone—multiple sclerosis	0.000841	0.00255	CcSEcCtD
Zileuton—Vomiting—Mitoxantrone—multiple sclerosis	0.000829	0.00251	CcSEcCtD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000823	0.00336	CbGpPWpGaD
Zileuton—Rash—Mitoxantrone—multiple sclerosis	0.000822	0.00249	CcSEcCtD
Zileuton—Dermatitis—Mitoxantrone—multiple sclerosis	0.000821	0.00249	CcSEcCtD
Zileuton—ALOX5—Selenium Micronutrient Network—IFNG—multiple sclerosis	0.000821	0.00336	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—LINGO1—multiple sclerosis	0.000818	0.00334	CbGpPWpGaD
Zileuton—Headache—Mitoxantrone—multiple sclerosis	0.000817	0.00247	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000813	0.00246	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000813	0.00246	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—MYC—multiple sclerosis	0.000811	0.00331	CbGpPWpGaD
Zileuton—Arthralgia—Prednisone—multiple sclerosis	0.000811	0.00245	CcSEcCtD
Zileuton—Myalgia—Prednisone—multiple sclerosis	0.000811	0.00245	CcSEcCtD
Zileuton—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00081	0.00245	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—TGFB1—multiple sclerosis	0.000809	0.00331	CbGpPWpGaD
Zileuton—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000809	0.00245	CcSEcCtD
Zileuton—LTB4R—GPCR ligand binding—CXCL10—multiple sclerosis	0.000808	0.0033	CbGpPWpGaD
Zileuton—Insomnia—Dexamethasone—multiple sclerosis	0.000807	0.00244	CcSEcCtD
Zileuton—Insomnia—Betamethasone—multiple sclerosis	0.000807	0.00244	CcSEcCtD
Zileuton—UGT1A9—PPAR Alpha Pathway—MYC—multiple sclerosis	0.000805	0.00329	CbGpPWpGaD
Zileuton—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000804	0.00329	CbGpPWpGaD
Zileuton—Discomfort—Prednisone—multiple sclerosis	0.000801	0.00242	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—MAPK1—multiple sclerosis	0.000793	0.00324	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—CYP27B1—multiple sclerosis	0.000789	0.00322	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—CYP24A1—multiple sclerosis	0.000789	0.00322	CbGpPWpGaD
Zileuton—Hypersensitivity—Prednisolone—multiple sclerosis	0.000788	0.00238	CcSEcCtD
Zileuton—Dyspepsia—Betamethasone—multiple sclerosis	0.000785	0.00238	CcSEcCtD
Zileuton—Dyspepsia—Dexamethasone—multiple sclerosis	0.000785	0.00238	CcSEcCtD
Zileuton—PTGS1—Overview of nanoparticle effects—TNF—multiple sclerosis	0.000785	0.00321	CbGpPWpGaD
Zileuton—Urticaria—Triamcinolone—multiple sclerosis	0.000781	0.00236	CcSEcCtD
Zileuton—Urticaria—Methylprednisolone—multiple sclerosis	0.00078	0.00236	CcSEcCtD
Zileuton—Body temperature increased—Triamcinolone—multiple sclerosis	0.000777	0.00235	CcSEcCtD
Zileuton—Nausea—Mitoxantrone—multiple sclerosis	0.000774	0.00234	CcSEcCtD
Zileuton—LTB4R—Signaling by GPCR—CCR1—multiple sclerosis	0.000774	0.00316	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CXCL13—multiple sclerosis	0.000774	0.00316	CbGpPWpGaD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000771	0.00315	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000771	0.00315	CbGpPWpGaD
Zileuton—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00077	0.00233	CcSEcCtD
Zileuton—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00077	0.00233	CcSEcCtD
Zileuton—Pain—Dexamethasone—multiple sclerosis	0.000763	0.00231	CcSEcCtD
Zileuton—Pain—Betamethasone—multiple sclerosis	0.000763	0.00231	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—TNF—multiple sclerosis	0.000755	0.00309	CbGpPWpGaD
Zileuton—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000738	0.00223	CcSEcCtD
Zileuton—Feeling abnormal—Betamethasone—multiple sclerosis	0.000735	0.00223	CcSEcCtD
Zileuton—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000735	0.00223	CcSEcCtD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	0.000734	0.003	CbGpPWpGaD
Zileuton—ALOX5—Selenium Micronutrient Network—IL1B—multiple sclerosis	0.000732	0.00299	CbGpPWpGaD
Zileuton—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000726	0.00297	CbGpPWpGaD
Zileuton—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000726	0.00297	CbGpPWpGaD
Zileuton—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000725	0.00219	CcSEcCtD
Zileuton—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000723	0.00219	CcSEcCtD
Zileuton—EPHX2—Metabolism—GPC5—multiple sclerosis	0.000722	0.00295	CbGpPWpGaD
Zileuton—Malaise—Methotrexate—multiple sclerosis	0.000718	0.00217	CcSEcCtD
Zileuton—LTB4R—Signaling Pathways—TAGAP—multiple sclerosis	0.00071	0.0029	CbGpPWpGaD
Zileuton—Urticaria—Dexamethasone—multiple sclerosis	0.000709	0.00215	CcSEcCtD
Zileuton—Urticaria—Betamethasone—multiple sclerosis	0.000709	0.00215	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000708	0.00214	CcSEcCtD
Zileuton—Dizziness—Prednisolone—multiple sclerosis	0.000707	0.00214	CcSEcCtD
Zileuton—Body temperature increased—Betamethasone—multiple sclerosis	0.000705	0.00213	CcSEcCtD
Zileuton—Body temperature increased—Dexamethasone—multiple sclerosis	0.000705	0.00213	CcSEcCtD
Zileuton—Insomnia—Prednisone—multiple sclerosis	0.000703	0.00213	CcSEcCtD
Zileuton—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.0007	0.00286	CbGpPWpGaD
Zileuton—Pruritus—Triamcinolone—multiple sclerosis	0.000696	0.00211	CcSEcCtD
Zileuton—LTB4R—GPCR ligand binding—CCL5—multiple sclerosis	0.000695	0.00284	CbGpPWpGaD
Zileuton—Pruritus—Methylprednisolone—multiple sclerosis	0.000694	0.0021	CcSEcCtD
Zileuton—Dyspepsia—Prednisone—multiple sclerosis	0.000684	0.00207	CcSEcCtD
Zileuton—Myalgia—Methotrexate—multiple sclerosis	0.000677	0.00205	CcSEcCtD
Zileuton—Chest pain—Methotrexate—multiple sclerosis	0.000677	0.00205	CcSEcCtD
Zileuton—Arthralgia—Methotrexate—multiple sclerosis	0.000677	0.00205	CcSEcCtD
Zileuton—Rash—Prednisolone—multiple sclerosis	0.000674	0.00204	CcSEcCtD
Zileuton—Dermatitis—Prednisolone—multiple sclerosis	0.000674	0.00204	CcSEcCtD
Zileuton—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000671	0.00203	CcSEcCtD
Zileuton—Headache—Prednisolone—multiple sclerosis	0.00067	0.00203	CcSEcCtD
Zileuton—Discomfort—Methotrexate—multiple sclerosis	0.000669	0.00203	CcSEcCtD
Zileuton—Constipation—Prednisone—multiple sclerosis	0.000665	0.00201	CcSEcCtD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	0.000654	0.00267	CbGpPWpGaD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	0.000652	0.00266	CbGpPWpGaD
Zileuton—Dizziness—Triamcinolone—multiple sclerosis	0.00065	0.00197	CcSEcCtD
Zileuton—Dizziness—Methylprednisolone—multiple sclerosis	0.000649	0.00196	CcSEcCtD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000643	0.00263	CbGpPWpGaD
Zileuton—Feeling abnormal—Prednisone—multiple sclerosis	0.00064	0.00194	CcSEcCtD
Zileuton—Nausea—Prednisolone—multiple sclerosis	0.000635	0.00192	CcSEcCtD
Zileuton—PTGS1—Overview of nanoparticle effects—IL6—multiple sclerosis	0.000634	0.00259	CbGpPWpGaD
Zileuton—Pruritus—Betamethasone—multiple sclerosis	0.000631	0.00191	CcSEcCtD
Zileuton—Pruritus—Dexamethasone—multiple sclerosis	0.000631	0.00191	CcSEcCtD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000629	0.00257	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—CCR5—multiple sclerosis	0.000626	0.00256	CbGpPWpGaD
Zileuton—Vomiting—Triamcinolone—multiple sclerosis	0.000625	0.00189	CcSEcCtD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000625	0.00255	CbGpPWpGaD
Zileuton—Vomiting—Methylprednisolone—multiple sclerosis	0.000624	0.00189	CcSEcCtD
Zileuton—ALOX5—Metabolism—SRM—multiple sclerosis	0.000623	0.00255	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—S1PR1—multiple sclerosis	0.00062	0.00253	CbGpPWpGaD
Zileuton—Rash—Triamcinolone—multiple sclerosis	0.00062	0.00188	CcSEcCtD
Zileuton—Dermatitis—Triamcinolone—multiple sclerosis	0.00062	0.00187	CcSEcCtD
Zileuton—Rash—Methylprednisolone—multiple sclerosis	0.000619	0.00187	CcSEcCtD
Zileuton—Dermatitis—Methylprednisolone—multiple sclerosis	0.000618	0.00187	CcSEcCtD
Zileuton—Urticaria—Prednisone—multiple sclerosis	0.000617	0.00187	CcSEcCtD
Zileuton—Headache—Triamcinolone—multiple sclerosis	0.000616	0.00186	CcSEcCtD
Zileuton—Headache—Methylprednisolone—multiple sclerosis	0.000615	0.00186	CcSEcCtD
Zileuton—Body temperature increased—Prednisone—multiple sclerosis	0.000614	0.00186	CcSEcCtD
Zileuton—Diarrhoea—Betamethasone—multiple sclerosis	0.000611	0.00185	CcSEcCtD
Zileuton—Diarrhoea—Dexamethasone—multiple sclerosis	0.000611	0.00185	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—IL6—multiple sclerosis	0.00061	0.00249	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—GPC5—multiple sclerosis	0.000603	0.00247	CbGpPWpGaD
Zileuton—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000598	0.00244	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—RRM1—multiple sclerosis	0.000598	0.00244	CbGpPWpGaD
Zileuton—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000592	0.00179	CcSEcCtD
Zileuton—Dizziness—Betamethasone—multiple sclerosis	0.00059	0.00179	CcSEcCtD
Zileuton—Dizziness—Dexamethasone—multiple sclerosis	0.00059	0.00179	CcSEcCtD
Zileuton—Insomnia—Methotrexate—multiple sclerosis	0.000587	0.00178	CcSEcCtD
Zileuton—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000585	0.00239	CbGpPWpGaD
Zileuton—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000585	0.00239	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000585	0.00239	CbGpPWpGaD
Zileuton—Nausea—Triamcinolone—multiple sclerosis	0.000584	0.00177	CcSEcCtD
Zileuton—Nausea—Methylprednisolone—multiple sclerosis	0.000583	0.00176	CcSEcCtD
Zileuton—Somnolence—Methotrexate—multiple sclerosis	0.000577	0.00175	CcSEcCtD
Zileuton—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000577	0.00236	CbGpPWpGaD
Zileuton—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000577	0.00236	CbGpPWpGaD
Zileuton—Hypersensitivity—Prednisone—multiple sclerosis	0.000573	0.00173	CcSEcCtD
Zileuton—Dyspepsia—Methotrexate—multiple sclerosis	0.000572	0.00173	CcSEcCtD
Zileuton—Vomiting—Dexamethasone—multiple sclerosis	0.000567	0.00172	CcSEcCtD
Zileuton—Vomiting—Betamethasone—multiple sclerosis	0.000567	0.00172	CcSEcCtD
Zileuton—LTB4R—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000565	0.00231	CbGpPWpGaD
Zileuton—Rash—Betamethasone—multiple sclerosis	0.000563	0.0017	CcSEcCtD
Zileuton—Rash—Dexamethasone—multiple sclerosis	0.000563	0.0017	CcSEcCtD
Zileuton—Dermatitis—Dexamethasone—multiple sclerosis	0.000562	0.0017	CcSEcCtD
Zileuton—Dermatitis—Betamethasone—multiple sclerosis	0.000562	0.0017	CcSEcCtD
Zileuton—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000561	0.0017	CcSEcCtD
Zileuton—Headache—Betamethasone—multiple sclerosis	0.000559	0.00169	CcSEcCtD
Zileuton—Headache—Dexamethasone—multiple sclerosis	0.000559	0.00169	CcSEcCtD
Zileuton—Pain—Methotrexate—multiple sclerosis	0.000555	0.00168	CcSEcCtD
Zileuton—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000552	0.00226	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CCL3—multiple sclerosis	0.000552	0.00225	CbGpPWpGaD
Zileuton—Pruritus—Prednisone—multiple sclerosis	0.00055	0.00166	CcSEcCtD
Zileuton—LTB4R—GPCR downstream signaling—CCR2—multiple sclerosis	0.000549	0.00224	CbGpPWpGaD
Zileuton—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000544	0.00222	CbGpPWpGaD
Zileuton—Feeling abnormal—Methotrexate—multiple sclerosis	0.000535	0.00162	CcSEcCtD
Zileuton—Diarrhoea—Prednisone—multiple sclerosis	0.000532	0.00161	CcSEcCtD
Zileuton—ALOX5—Selenium Micronutrient Network—TNF—multiple sclerosis	0.000531	0.00217	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—PTGER4—multiple sclerosis	0.000531	0.00217	CbGpPWpGaD
Zileuton—Nausea—Betamethasone—multiple sclerosis	0.00053	0.0016	CcSEcCtD
Zileuton—Nausea—Dexamethasone—multiple sclerosis	0.00053	0.0016	CcSEcCtD
Zileuton—LTB4R—Signaling Pathways—RGS1—multiple sclerosis	0.000527	0.00216	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000524	0.00214	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000524	0.00214	CbGpPWpGaD
Zileuton—Urticaria—Methotrexate—multiple sclerosis	0.000516	0.00156	CcSEcCtD
Zileuton—Dizziness—Prednisone—multiple sclerosis	0.000514	0.00156	CcSEcCtD
Zileuton—Body temperature increased—Methotrexate—multiple sclerosis	0.000513	0.00155	CcSEcCtD
Zileuton—LTB4R—Signaling by GPCR—CXCR3—multiple sclerosis	0.000513	0.0021	CbGpPWpGaD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	0.000509	0.00208	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—CNR1—multiple sclerosis	0.000507	0.00207	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—GPR65—multiple sclerosis	0.0005	0.00204	CbGpPWpGaD
Zileuton—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.0005	0.00204	CbGpPWpGaD
Zileuton—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.0005	0.00204	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CCR2—multiple sclerosis	0.000499	0.00204	CbGpPWpGaD
Zileuton—Vomiting—Prednisone—multiple sclerosis	0.000494	0.0015	CcSEcCtD
Zileuton—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000493	0.00201	CbGpPWpGaD
Zileuton—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000493	0.00201	CbGpPWpGaD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000491	0.00201	CbGpPWpGaD
Zileuton—Rash—Prednisone—multiple sclerosis	0.00049	0.00148	CcSEcCtD
Zileuton—Dermatitis—Prednisone—multiple sclerosis	0.00049	0.00148	CcSEcCtD
Zileuton—LTB4R—GPCR ligand binding—POMC—multiple sclerosis	0.00049	0.002	CbGpPWpGaD
Zileuton—Headache—Prednisone—multiple sclerosis	0.000487	0.00147	CcSEcCtD
Zileuton—LTB4R—GPCR ligand binding—CCL2—multiple sclerosis	0.000479	0.00196	CbGpPWpGaD
Zileuton—Hypersensitivity—Methotrexate—multiple sclerosis	0.000478	0.00145	CcSEcCtD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	0.000475	0.00194	CbGpPWpGaD
Zileuton—PTGS1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000471	0.00193	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—ICAM1—multiple sclerosis	0.000468	0.00191	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000464	0.0019	CbGpPWpGaD
Zileuton—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000462	0.00189	CbGpPWpGaD
Zileuton—Nausea—Prednisone—multiple sclerosis	0.000462	0.0014	CcSEcCtD
Zileuton—LTB4R—Signaling by GPCR—CNR1—multiple sclerosis	0.00046	0.00188	CbGpPWpGaD
Zileuton—Pruritus—Methotrexate—multiple sclerosis	0.000459	0.00139	CcSEcCtD
Zileuton—LTB4R—Signaling Pathways—CXCL13—multiple sclerosis	0.000457	0.00187	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CCR1—multiple sclerosis	0.000457	0.00187	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000456	0.00187	CbGpPWpGaD
Zileuton—Diarrhoea—Methotrexate—multiple sclerosis	0.000444	0.00134	CcSEcCtD
Zileuton—ALOX5—Metabolism—CYP24A1—multiple sclerosis	0.000439	0.00179	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—CYP27B1—multiple sclerosis	0.000439	0.00179	CbGpPWpGaD
Zileuton—Dizziness—Methotrexate—multiple sclerosis	0.000429	0.0013	CcSEcCtD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000429	0.00175	CbGpPWpGaD
Zileuton—ALOX5—Selenium Micronutrient Network—IL6—multiple sclerosis	0.000429	0.00175	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000427	0.00175	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000427	0.00175	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—CCL2—multiple sclerosis	0.000419	0.00171	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CXCL10—multiple sclerosis	0.000414	0.00169	CbGpPWpGaD
Zileuton—Vomiting—Methotrexate—multiple sclerosis	0.000413	0.00125	CcSEcCtD
Zileuton—Rash—Methotrexate—multiple sclerosis	0.000409	0.00124	CcSEcCtD
Zileuton—Dermatitis—Methotrexate—multiple sclerosis	0.000409	0.00124	CcSEcCtD
Zileuton—Headache—Methotrexate—multiple sclerosis	0.000407	0.00123	CcSEcCtD
Zileuton—ALOX5—Metabolism—GPC5—multiple sclerosis	0.000401	0.00164	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000399	0.00163	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—CCL5—multiple sclerosis	0.000393	0.00161	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—ALB—multiple sclerosis	0.00039	0.00159	CbGpPWpGaD
Zileuton—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000386	0.00158	CbGpPWpGaD
Zileuton—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000386	0.00158	CbGpPWpGaD
Zileuton—Nausea—Methotrexate—multiple sclerosis	0.000386	0.00117	CcSEcCtD
Zileuton—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00038	0.00156	CbGpPWpGaD
Zileuton—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00038	0.00156	CbGpPWpGaD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000377	0.00154	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000363	0.00148	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CCL5—multiple sclerosis	0.000357	0.00146	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—IFNG—multiple sclerosis	0.000356	0.00145	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—CCR5—multiple sclerosis	0.000354	0.00145	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000349	0.00143	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—BCHE—multiple sclerosis	0.000343	0.0014	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—RRM1—multiple sclerosis	0.000333	0.00136	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—SRM—multiple sclerosis	0.000331	0.00135	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CCL3—multiple sclerosis	0.000326	0.00133	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CCR5—multiple sclerosis	0.000321	0.00131	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—IL1B—multiple sclerosis	0.000318	0.0013	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—IL2RA—multiple sclerosis	0.000317	0.00129	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PTGER4—multiple sclerosis	0.000314	0.00128	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PGR—multiple sclerosis	0.000309	0.00126	CbGpPWpGaD
Zileuton—UGT1A9—Biological oxidations—POMC—multiple sclerosis	0.000307	0.00125	CbGpPWpGaD
Zileuton—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000306	0.00125	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CXCR3—multiple sclerosis	0.000303	0.00124	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CD28—multiple sclerosis	0.0003	0.00123	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CCR2—multiple sclerosis	0.000295	0.0012	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—POMC—multiple sclerosis	0.000277	0.00113	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CNR1—multiple sclerosis	0.000272	0.00111	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—SRM—multiple sclerosis	0.00027	0.0011	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	0.000269	0.0011	CbGpPWpGaD
Zileuton—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000261	0.00107	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000258	0.00105	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—POMC—multiple sclerosis	0.000251	0.00103	CbGpPWpGaD
Zileuton—PTGS1—Biological oxidations—POMC—multiple sclerosis	0.00025	0.00102	CbGpPWpGaD
Zileuton—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000248	0.00101	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CCL2—multiple sclerosis	0.000246	0.001	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CXCL10—multiple sclerosis	0.000245	0.001	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	0.00024	0.00098	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	0.000239	0.000976	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CYP27B1—multiple sclerosis	0.000233	0.000954	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CYP24A1—multiple sclerosis	0.000233	0.000954	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—TNF—multiple sclerosis	0.00023	0.000942	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000228	0.000932	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000225	0.000918	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000225	0.000918	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—TYK2—multiple sclerosis	0.000223	0.000912	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000222	0.000906	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CD86—multiple sclerosis	0.000214	0.000875	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—GPC5—multiple sclerosis	0.000214	0.000873	CbGpPWpGaD
Zileuton—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000212	0.000865	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CCL5—multiple sclerosis	0.000211	0.000861	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—APOE—multiple sclerosis	0.000207	0.000844	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—IL2—multiple sclerosis	0.000205	0.000836	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000202	0.000826	CbGpPWpGaD
Zileuton—UGT1A9—NRF2 pathway—TGFB1—multiple sclerosis	0.000202	0.000825	CbGpPWpGaD
Zileuton—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000202	0.000824	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—SPP1—multiple sclerosis	0.000195	0.000798	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000192	0.000784	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000192	0.000784	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—BCHE—multiple sclerosis	0.000191	0.000781	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CYP27B1—multiple sclerosis	0.00019	0.000778	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CYP24A1—multiple sclerosis	0.00019	0.000778	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CCR5—multiple sclerosis	0.00019	0.000776	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IL2RA—multiple sclerosis	0.000187	0.000765	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	0.000187	0.000763	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	0.000186	0.000761	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000186	0.00076	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	0.000186	0.00076	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—IL2—multiple sclerosis	0.000186	0.000759	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	0.000183	0.000746	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—POMC—multiple sclerosis	0.000177	0.000725	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—RRM1—multiple sclerosis	0.000177	0.000723	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—GPC5—multiple sclerosis	0.000174	0.000711	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	0.000174	0.000711	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	0.000174	0.000711	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—APOE—multiple sclerosis	0.000173	0.000706	CbGpPWpGaD
Zileuton—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000163	0.000668	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—ALB—multiple sclerosis	0.000162	0.000661	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CD80—multiple sclerosis	0.000156	0.000638	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—POMC—multiple sclerosis	0.000148	0.000606	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CCL2—multiple sclerosis	0.000145	0.000593	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—RRM1—multiple sclerosis	0.000144	0.000589	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—MAPK1—multiple sclerosis	0.000142	0.000581	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—SRM—multiple sclerosis	0.000142	0.00058	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000137	0.000561	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—TYK2—multiple sclerosis	0.000132	0.000539	CbGpPWpGaD
Zileuton—CYP2C9—Biological oxidations—POMC—multiple sclerosis	0.000132	0.000538	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—SRM—multiple sclerosis	0.000121	0.000496	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000118	0.000482	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—APOE—multiple sclerosis	0.000115	0.00047	CbGpPWpGaD
Zileuton—CYP1A2—Biological oxidations—POMC—multiple sclerosis	0.000112	0.00046	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000112	0.000457	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IL2—multiple sclerosis	0.00011	0.000448	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—IL6—multiple sclerosis	0.000109	0.000446	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000107	0.000439	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MMP9—multiple sclerosis	0.000104	0.000424	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—BCHE—multiple sclerosis	0.000102	0.000415	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	0.0001	0.000409	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	0.0001	0.000409	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—POMC—multiple sclerosis	9.87e-05	0.000403	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	9.78e-05	0.0004	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.61e-05	0.000393	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—SRM—multiple sclerosis	9.36e-05	0.000383	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—STAT3—multiple sclerosis	9.23e-05	0.000377	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GPC5—multiple sclerosis	9.15e-05	0.000374	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—ALB—multiple sclerosis	9e-05	0.000368	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.76e-05	0.000358	CbGpPWpGaD
Zileuton—CYP3A4—Biological oxidations—POMC—multiple sclerosis	8.68e-05	0.000355	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MYC—multiple sclerosis	8.58e-05	0.000351	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—TGFB1—multiple sclerosis	8.56e-05	0.00035	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	8.55e-05	0.000349	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	8.55e-05	0.000349	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MAPK1—multiple sclerosis	8.39e-05	0.000343	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	8.36e-05	0.000341	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—BCHE—multiple sclerosis	8.28e-05	0.000339	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GPC5—multiple sclerosis	7.82e-05	0.00032	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—RRM1—multiple sclerosis	7.58e-05	0.00031	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	6.6e-05	0.00027	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	6.6e-05	0.00027	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—RRM1—multiple sclerosis	6.48e-05	0.000265	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IL6—multiple sclerosis	6.45e-05	0.000264	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—APOE—multiple sclerosis	6.11e-05	0.00025	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GPC5—multiple sclerosis	6.03e-05	0.000247	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.88e-05	0.00024	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—POMC—multiple sclerosis	5.25e-05	0.000215	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.05e-05	0.000207	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.03e-05	0.000205	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—RRM1—multiple sclerosis	5e-05	0.000204	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—APOE—multiple sclerosis	4.98e-05	0.000204	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—ALB—multiple sclerosis	4.79e-05	0.000196	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.61e-05	0.000188	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—BCHE—multiple sclerosis	4.35e-05	0.000178	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.32e-05	0.000176	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—POMC—multiple sclerosis	4.28e-05	0.000175	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.94e-05	0.000161	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ALB—multiple sclerosis	3.9e-05	0.000159	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—BCHE—multiple sclerosis	3.72e-05	0.000152	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—BCHE—multiple sclerosis	2.87e-05	0.000117	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—APOE—multiple sclerosis	2.62e-05	0.000107	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—POMC—multiple sclerosis	2.25e-05	9.2e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—APOE—multiple sclerosis	2.24e-05	9.15e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ALB—multiple sclerosis	2.05e-05	8.38e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—POMC—multiple sclerosis	1.92e-05	7.86e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ALB—multiple sclerosis	1.75e-05	7.17e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—APOE—multiple sclerosis	1.73e-05	7.06e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—POMC—multiple sclerosis	1.48e-05	6.07e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ALB—multiple sclerosis	1.35e-05	5.53e-05	CbGpPWpGaD
